Jiefang Chen Selected Research

Jiefang Chen Research Topics

Disease

3	Atherosclerosis 01/2021 - 01/2020
2	Neoplasms (Cancer) 01/2022 - 01/2021
2	Stroke (Strokes) 12/2021 - 11/2013
2	Infections 02/2020 - 11/2013
1	Immune System Diseases (Immune Disorders) 01/2022
1	Nervous System Diseases (Neurological Disorders) 01/2022
1	Kidney Diseases (Kidney Disease) 01/2022
1	Ischemic Stroke 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Inflammation (Inflammations) 12/2021
1	Pathologic Processes 01/2021
1	Tics (Tic) 01/2021
1	Headache (Headaches) 02/2020
1	Proteinuria 02/2020
1	Atherosclerotic Plaque (Atheroma) 01/2020
1	Epilepsy (Aura) 01/2017
1	Gastrointestinal Hemorrhage (Hematochezia) 11/2013

Drug/Important Bio-Agent (IBA)

2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2020
2	Clopidogrel (Plavix)FDA Link 01/2021 - 01/2020
2	Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA 01/2021 - 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2022
1	BilirubinIBA 01/2022
1	MethyltransferasesIBA 01/2022
1	Untranslated RNA (Noncoding RNA)IBA 01/2022
1	Histone Deacetylase InhibitorsIBA 01/2022
1	InflammasomesIBA 12/2021
1	OligosaccharidesIBA 12/2021
1	HDL LipoproteinsIBA 01/2021
1	LDL CholesterolIBA 01/2021
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2021
1	Autophagy-Related Protein-1 HomologIBA 01/2021
1	DAPIIBA 01/2021
1	oil red OIBA 01/2021
1	2-methylthioadenosineIBA 01/2021
1	S- (N- monomethoxytritylaminoethyl)- O- (2- chlorophenyl)phosphorothioateIBA 01/2021
1	7- nitrobenz- 2- oxa- 1,3- diazol- 4- ylcholesterolIBA 01/2021
1	oxidized low density lipoproteinIBA 01/2021
1	MK 2206IBA 01/2021
1	Atorvastatin (Lipitor)FDA Link 01/2021
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2021
1	TicagrelorIBA 01/2021
1	Adenosine (Adenocard)FDA LinkGeneric 01/2021
1	Adenosine Triphosphate (ATP)IBA 01/2021
1	Apolipoproteins E (ApoE)IBA 01/2021
1	Carrier Proteins (Binding Protein)IBA 01/2021
1	Chloroquine (Aralen)FDA LinkGeneric 01/2021
1	CholesterolIBA 01/2021
1	BucladesineIBA 01/2021
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2021
1	Hematoxylin (Haematoxylon)IBA 01/2021
1	LipidsIBA 01/2021
1	Lipoproteins (Lipoprotein)IBA 01/2021
1	Peptide Initiation Factors (Initiation Factor)IBA 01/2021
1	Diphosphates (Pyrophosphates)IBA 01/2021
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2021
1	Class E Scavenger Receptors (Lectin Like Oxidized Low Density Lipoprotein Receptor 1)IBA 01/2021
1	AMP-Activated Protein KinasesIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 02/2020
1	CreatinineIBA 02/2020
1	Prednisone (Sone)FDA LinkGeneric 02/2020
1	Purinergic P2Y ReceptorsIBA 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Pentylenetetrazole (Metrazol)IBA 01/2017
1	Histidine (L-Histidine)FDA Link 01/2017
1	Histamine H2 ReceptorsIBA 01/2017
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2017
1	Hemoglobins (Hemoglobin)IBA 11/2013
1	AlbuminsIBA 11/2013

Therapy/Procedure

2	Therapeutics 01/2022 - 01/2021
1	Enteral Nutrition (Feeding, Tube) 11/2013
1	Nutritional Support (Artificial Feeding) 11/2013